Skip to content

PHARMALEC

Active
Private limited companyfounded 20179 yrs activeLenneke Marelaan 34, 1932 Zaventem, BelgiumKBO/BCE: BE 0678.956.844
Summary

PHARMALEC has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €513k and a net result of €93k. Equity is growing by ~38.4% per year across the filed fiscal years. Its solvency ranks better than 49% of 14128 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Checked score

Score 2025
Axes · tick = 2024
Profitability72▲+8
Solvency53▲+5
Growth78=
Track record100
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €30k at 30 days acceptable
Liquidity short (current ratio 0.26 against 0.33 in 2024; short-term debt: 18.9% and cash: 0.1% of total assets), and 71.6% of the assets are financed with debt.
Credit check for your own amount and term

Signals

Three signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 68
Relative position
BE, all sectors
reference
Real estate activities (NACE 68)
about 43% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
28.4%
Return on assets
5.1%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-07-2026, 1 day ahead of the deadline.
NBB · 8 filings
Deviation from the deadline
2025
1 d early
2024
28 d late
2023
37 d early
2022
31 d late
2021
26 d late
2020
17 d early
2019
7 d early
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
25-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€513k▲ 22.1%
2024 · €420k
2018: €12klowest in 8 years 2019: €53k▲ +334% vs 2018 2020: €83k▲ +57.5% vs 2019 2021: €156k▲ +88.1% vs 2020 2022: €225k▲ +44.9% vs 2021 2023: €341k▲ +51.3% vs 2022 2024: €420k▲ +23.2% vs 2023 2025: €513k▲ +22.1% vs 2024highest in 8 years
2018 → 2025
Total assets
€1.81M▼ 1.4%
2024 · €1.83M
2018: €339klowest in 8 years 2019: €362k▲ +6.8% vs 2018 2020: €383k▲ +5.6% vs 2019 2021: €1.21M▲ +216% vs 2020 2022: €1.20M▼ -0.7% vs 2021 2023: €1.25M▲ +4.2% vs 2022 2024: €1.83M▲ +46.1% vs 2023highest in 8 years 2025: €1.81M▼ -1.4% vs 2024
2018 → 2025
Net result
€93k▲ 17.2%
2024 · €79k
2018: €6klowest in 8 years 2019: €40k▲ +585% vs 2018 2020: €30k▼ -25.3% vs 2019 2021: €73k▲ +141% vs 2020 2022: €70k▼ -4.1% vs 2021 2023: €116k▲ +65.4% vs 2022highest in 8 years 2024: €79k▼ -31.4% vs 2023 2025: €93k▲ +17.2% vs 2024
2018 → 2025
Working capital
€-254k▼ 9.1%
2024 · €-233k
2018: €-26k 2019: €2k▲ +107% vs 2018 2020: €20k▲ +1048% vs 2019highest in 8 years 2021: €-117k▼ -694% vs 2020 2022: €-124k▼ -5.9% vs 2021 2023: €-86k▲ +30.7% vs 2022 2024: €-233k▼ -171% vs 2023 2025: €-254k▼ -9.1% vs 2024lowest in 8 years
2018 → 2025
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€156k-€225k▲ 44.9%€341k▲ 51.3%€420k▲ 23.2%€513k▲ 22.1% 2021: €156klowest in 5 years 2022: €225k▲ +44.9% vs 2021 2023: €341k▲ +51.3% vs 2022 2024: €420k▲ +23.2% vs 2023 2025: €513k▲ +22.1% vs 2024highest in 5 years
Operating result€118k-€114k▼ 3.1%€177k▲ 54.5%€135k▼ 23.4%€152k▲ 12.3% 2021: €118k 2022: €114k▼ -3.1% vs 2021lowest in 5 years 2023: €177k▲ +54.5% vs 2022highest in 5 years 2024: €135k▼ -23.4% vs 2023 2025: €152k▲ +12.3% vs 2024
Net result€73k-€70k▼ 4.1%€116k▲ 65.4%€79k▼ 31.4%€93k▲ 17.2% 2021: €73k 2022: €70k▼ -4.1% vs 2021lowest in 5 years 2023: €116k▲ +65.4% vs 2022highest in 5 years 2024: €79k▼ -31.4% vs 2023 2025: €93k▲ +17.2% vs 2024
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50k€100k€150k€200kOperating result 2021: €118k€118kNet result 2021: €73k€73kOperating result 2022: €114k€114kNet result 2022: €70k€70kOperating result 2023: €177k€177kNet result 2023: €116k€116kOperating result 2024: €135k€135kNet result 2024: €79k€79kOperating result 2025: €152k€152kNet result 2025: €93k€93k20212022202320242025€0€50k€100k€150k€200kOperating result 2023: €177k€177kNet result 2023: €116k€116kOperating result 2024: €135k€135kNet result 2024: €79k€79kOperating result 2025: €152k€152kNet result 2025: €93k€93k202320242025
The operating result recovers in 2025; 2025 is 12% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.81M
Fixed assets €1.72M ▲ 0.2%
Current assets €88k ▼ 24.8%
Equity and liabilities €1.81M
Equity €513k ▲ 22.1%
Debt €1.29M ▼ 8.4%
Debt's share of the balance-sheet total falls from 77.1% to 71.6%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€156k▲
2024 · €138k
Cash flow
€97k▲
2024 · €82k
Current ratio
0.26▼
2024 · 0.33
Debt to equity
2.52▼
2024 · 3.36
ROE
18.1%▼
2024 · 18.9%
ROA
5.1%▲
2024 · 4.3%
Interest coverage
5.66▲
2024 · 4.74
Debt ≤ 1 year
€342k▼
2024 · €350k
Debt > 1 year
€951k▼
2024 · €1.06M
Income taxes
€32k▲
2024 · €27k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 46 lines
Balance sheet Code20242025
Assets
Total assets20/58€1.83M€1.81M▼
Fixed assets21/28€1.71M€1.72M▲
Tangible fixed assets22/27€111k€115k▲
Land and buildings22€111k€108k▼
Furniture and vehicles24-€7k
Financial fixed assets28€1.60M€1.60M=
Current assets29/58€117k€88k▼
Amounts receivable within one year40/41€101k€87k▼
Trade receivables40€41k€58k▲
Other amounts receivable41€60k€29k▼
Cash at bank and in hand54/58€16k€1k▼
Equity and liabilities
Total equity and liabilities10/49€1.83M€1.81M▼
Equity10/15€420k€513k▲
Contributions10/11€6k€6k=
Reserves13€414k€507k▲
Distributable reserves133€414k€507k▲
Amounts payable17/49€1.41M€1.29M▼
Amounts payable after more than one year17€1.06M€951k▼
Financial debts170/4€1.06M€951k▼
Amounts payable within one year42/48€350k€342k▼
Current portion of amounts payable after more than one year42€109k€110k▲
Trade debts44€65k€4k▼
Suppliers440/4€65k€4k▼
Advances received on contracts in progress46€5k€0▼
Taxes, remuneration and social security45€14k€22k▲
Taxes450/3€14k€22k▲
Other amounts payable47/48€157k€206k▲
Accrued charges and deferred income492/3-€200
Income statement Code20242025
Non-recurring operating income76A€81k€0▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3k€4k▲
Other operating charges640/8€3k€2k▼
Gross operating margin9900€142k€157k▲
Operating profit (loss)9901€135k€152k▲
Financial income75/76B-€1
Recurring financial income75-€1
Non-recurring financial income76B-€1
Financial charges65/66B€29k€28k▼
Recurring financial charges65€29k€28k▼
Non-recurring financial charges66B€228€0▼
Profit (loss) for the period before taxes9903€106k€124k▲
Income taxes67/77€27k€32k▲
Profit (loss) for the period9904€79k€93k▲
Profit (loss) for the period to be appropriated9905€79k€93k▲
Appropriation of the result
Profit (loss) to be appropriated9906€79k€93k▲
Transfer to equity691/2€79k€93k▲
To other reserves6921€79k€93k▲

The notes to these accounts (11 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Accounts by statement
Line20212022202320242025Change
Non-recurring operating income76A---€81k€0▼ 100%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€9k€9k€8k€3k€4k▲ 18.6%
Other operating charges640/8€2k€999€1k€3k€2k▼ 55.0%
Gross operating margin9900€128k€124k€186k€142k€157k▲ 10.8%
Operating profit (loss)9901€118k€114k€177k€135k€152k▲ 12.3%
Financial income75/76B----€1-
Recurring financial income75----€1-
Non-recurring financial income76B----€1-
Financial charges65/66B€17k€12k€7k€29k€28k▼ 6.6%
Recurring financial charges65€17k€12k€7k€29k€28k▼ 5.8%
Non-recurring financial charges66B-€89-€228€0▼ 100%
Profit (loss) for the period before taxes9903€101k€102k€170k€106k€124k▲ 17.6%
Income taxes67/77€28k€33k€54k€27k€32k▲ 18.7%
Profit (loss) for the period9904€73k€70k€116k€79k€93k▲ 17.2%
Profit (loss) for the period to be appropriated9905€73k€70k€116k€79k€93k▲ 17.2%
Line20212022202320242025Change
Assets
Total assets20/58€1.21M€1.20M€1.25M€1.83M€1.81M▼ 1.4%
Fixed assets21/28€1.14M€1.13M€1.12M€1.71M€1.72M▲ 0.2%
Tangible fixed assets22/27€303k€294k€286k€111k€115k▲ 3.6%
Land and buildings22€303k€294k€286k€111k€108k▼ 2.9%
Plant, machinery and equipment23€460-----
Furniture and vehicles24----€7k-
Financial fixed assets28€832k€832k€832k€1.60M€1.60M=
Current assets29/58€76k€76k€135k€117k€88k▼ 24.8%
Amounts receivable within one year40/41€72k€60k€122k€101k€87k▼ 14.1%
Trade receivables40€33k€23k€91k€41k€58k▲ 42.2%
Other amounts receivable41€39k€37k€32k€60k€29k▼ 52.1%
Cash at bank and in hand54/58€4k€16k€12k€16k€1k▼ 91.1%
Equity and liabilities
Total equity and liabilities10/49€1.21M€1.20M€1.25M€1.83M€1.81M▼ 1.4%
Equity10/15€156k€225k€341k€420k€513k▲ 22.1%
Contributions10/11€8k€8k€6k€6k€6k=
Reserves13€147k€217k€335k€414k€507k▲ 22.4%
Distributable reserves133€147k€217k€335k€414k€507k▲ 22.4%
Amounts payable17/49€1.06M€977k€912k€1.41M€1.29M▼ 8.4%
Amounts payable after more than one year17€863k€777k€692k€1.06M€951k▼ 10.4%
Financial debts170/4€863k€777k€692k€1.06M€951k▼ 10.4%
Amounts payable within one year42/48€193k€200k€221k€350k€342k▼ 2.3%
Current portion of amounts payable after more than one year42€85k€85k€86k€109k€110k▲ 1.0%
Financial debts43€8k-----
Credit institutions430/8€8k-----
Trade debts44€61€55-€65k€4k▼ 94.2%
Suppliers440/4€61€55-€65k€4k▼ 94.2%
Advances received on contracts in progress46---€5k€0▼ 100%
Taxes, remuneration and social security45€12k€9k€34k€14k€22k▲ 50.8%
Taxes450/3€12k€9k€34k€14k€22k▲ 50.8%
Other amounts payable47/48€87k€105k€101k€157k€206k▲ 31.8%
Accrued charges and deferred income492/3----€200-
Line20212022202320242025Change
Profit (loss) for the period9904€73k€70k€116k€79k€93k▲ 17.2%
+ Depreciation and write-downs630€9k€9k€8k€3k€4k▲ 18.6%
Operating cash flow (approximation)€81k€78k€124k€82k€97k▲ 17.3%
Investment in fixed assets (approximation)-€0€0€-599k€-8k▲ 98.7%
Change in cash-€12k€-3k€4k€-15k▼ 486%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Sign in to download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
30-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial Equity above €500kEq €513k ▲22.1%
8 profitable years in a row build equity to €513k.
28-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 28 days late
2024
24-06
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial Highest result since 2018net €116k ▲65.4%
Operating result €177k, net result €116k, both a record.
31-08
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 31 days late
2022
31-12
Financial Equity above €200kEq €225k ▲44.9%
5 profitable years in a row build equity to €225k.
26-08
NBB filing Annual accounts filed
fiscal year 2021 · micro schema · 26 days late
2021
31-12
Financial Equity above €150kEq €156k ▲88.1%
4 profitable years in a row build equity to €156k.
14-07
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
2020
24-07
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
2019
31-12
Financial Liquidity quadruplescurrent ratio 1.04
Current ratio from 0.26 to 1.04.
29-08
NBB filing Annual accounts filed
fiscal year 2018 · micro schema · 29 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts

We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Zaventem · 1 establishment unit since 2017
seat establishment The establishment unit on the map
Ground area
1.1 ha
Building footprint
243 m²
Volume, LiDAR
9,716 m³
Parcel 23078C0188/00F000, Flanders · tallest building 45.1 m, ±14 floors. Linked by address, not a title deed.
9 companies at this address See who is registered here
1 establishment unit
Pharmalec BVBA
Lenneke Marelaan 34, 1932 ZaventemRetail sale of pharmaceutical products
since 20172.285.728.586
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
23078C0188/00F000 Flanders 1.1 ha 1 · 243 m² 45.1 m · 14 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 9,136 companies in sector 68201 we hold annual accounts for 6,765. 5,028 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded28-07-2017
Fiscal year end31-12
Activities, NACEBEL 2025
68201Renting and operating of own or leased residential real estate, excluding social housing
47730Retail sale of pharmaceutical products

Scores and ratios are computed by Checked and are not a credit decision.